Jaguar Health Inc. logo

Jaguar Health Inc.

JAGX | NASDAQ
Chart Builder DCF Calculator
$0.87
-$0.75 (-46.30%)
Nov 2, 2026, 3:18 PM ET · Market open
Fiscal Quarter
Period Ending
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
Revenue
1.23M 20.27M 3.24M 3.08M 2.98M 2.21M 3.51M 3.11M 2.72M 2.35M 2.3M 2.81M 2.68M 1.97M 3.26M 3.15M 2.92M 2.63M 2.08M 630K 385K 1.24M
Cost of Revenue
1.03M 1.16M 2.2M 532K 527K 515K 557K 541K 427K 430K 687K 514K 491K 345K 495K 613K 456K 455K 469K 617K 664K 583K
Gross Profit
194K 19.11M 1.04M 2.55M 2.45M 1.7M 2.95M 2.57M 2.29M 1.92M 1.61M 2.3M 2.19M 1.63M 2.77M 2.54M 2.47M 2.17M 1.61M 13K -279K 658K
Operating Income
-7.6M 10.18M -20.44M -7.24M -8.01M -9.42M -8.16M -7.26M -7.2M -8.22M -7.56M -8.79M -8.1M -9.85M -6.29M -9.9M -6.48M -11.75M -10.82M -9.53M -11.58M -8.77M
Interest Income
n/a n/a n/a n/a 15K 56K 110K 162K 108K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-12.8M 8.72M -23.19M -9.65M -10.56M -10.6M -10.23M -10.02M -9.63M -9.37M -9.31M -7.9M -12.29M -12.4M -8.23M -12.61M -9.39M -18.16M -14.32M -12.19M -14.08M -12.01M
Net Income
-12.68M 8.6M -23.06M -9.5M -10.41M -10.46M -9.92M -9.85M -9.49M -9.23M -9.17M -7.78M -12.15M -12.2M -7.58M -12.52M -9.37M -17.99M -14.31M -12.19M -14.08M -12.01M
Selling & General & Admin
4.46M 5M 5.31M 6.13M 7.19M 7.39M 6.58M 5.79M 5.84M 5.82M 5.07M 5.01M 6.01M 6.7M 4.74M 6.49M 6.49M 8.98M 6.95M 6.23M 7.26M 5.55M
Research & Development
3.34M 3.93M 14.31M 3.66M 3.27M 3.73M 4.53M 4.04M 3.65M 4.31M 3.46M 6.08M 4.28M 4.78M 4.31M 5.94M 2.45M 4.95M 5.48M 3.31M 3.87M 2.41M
Other Expenses
n/a n/a 1.86M n/a n/a n/a n/a n/a n/a n/a 634K n/a 26K -12K n/a n/a n/a n/a n/a -20K 172K 1.46M
Operating Expenses
7.79M 8.93M 21.48M 9.79M 10.46M 11.12M 11.11M 9.83M 9.49M 10.14M 9.17M 11.09M 10.29M 11.47M 9.05M 12.43M 8.94M 13.92M 12.43M 9.54M 11.3M 9.42M
Interest Expense
161K 699K n/a 6K n/a n/a n/a n/a n/a 611K 248K 500K 3.45M 2.18M 2.63M 2.73M 2.54M 4.19M 2.43M 2.08M 2.01M 1.9M
Selling & Marketing Expenses
5K 896K 1.47M 737K 1.03M 1.24M 1.54M 2.01M 1.52M 661K 1.53M 637K 878K 1.88M 1.75M 2.11M 1.34M 2.84M 2.3M 2.26M 1.07M 2.14M
Cost & Expenses
8.82M 10.09M 23.68M 10.32M 10.99M 11.64M 11.67M 10.37M 9.92M 10.57M 9.86M 11.6M 10.78M 11.82M 9.55M 13.05M 9.4M 14.38M 12.9M 10.16M 11.97M 10.01M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
53.94K 34.39K 13.29K 2.88K 1.93K 1.19K 1.01K 713.87 179 201.67 92.87 26.34 22.39 6.49 2.81 1.80 1.35 0.76 0.85 0.78 0.76 0.71
Shares Outstanding (Diluted)
53.94K 34.39K 13.29K 2.88K 1.93K 1.19K 1.01K 713.87 179 201.67 92.87 26.34 22.39 6.49 2.81 1.80 1.35 0.76 0.85 0.78 0.76 0.71
EPS (Basic)
-235.50 -204 -1.75K -3.3K -5.38K -8.77K -9.86K -13.8K -53.03K -45.74K -98.73K -295.34K -542.67K -1.88M -2.7M -6.95M -6.94M -23.76M -16.75M -15.71M -18.56M -16.97M
EPS (Diluted)
-235.50 -204 -1.75K -3.3K -5.38K -8.77K -9.86K -13.8K -53.03K -45.74K -98.73K -295.34K -542.67K -1.88M -2.7M -6.95M -6.94M -23.76M -16.75M -15.71M -18.56M -16.97M
EBITDA
-12.22M 9.94M -28.72M -9.09M -10M -10.05M -15.75M -9.43M -9.07M -8.15M -6.68M -6.78M -8.22M -9.67M -5M -9.29M -6.21M -13.52M -11.39M -9.64M -11.64M -9.68M
EBIT
-12.64M 9.42M -29.26M -9.65M -10.56M -10.6M -16.35M -10.02M -9.63M -8.76M -7.19M -7.4M -8.84M -10.22M -5.6M -9.88M -6.85M -13.97M -11.89M -10.11M -12.07M -10.11M
Depreciation & Amortization
426K 520K 543K 557K 556K 546K 593K 596K 559K 610K 502K 625K 621K 551K 602K 587K 648K 455K 492K 473K 431K 431K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.